Infusion Therapy Market (Product: Infusion Pumps, Infusion Set, and Accessories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Infusion Therapy Market – Scope of Report
TMR’s report on the global infusion therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global infusion therapy market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global infusion therapy market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the infusion therapy market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global infusion therapy market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global infusion therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global infusion therapy market.
The report delves into the competitive landscape of the global infusion therapy market. Key players operating in the global infusion therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global infusion therapy market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market infusion therapy.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
- Industry Sources:
- WorldWideScience.org
- Elsevier, Inc.
- National Institutes of Health (NIH)
- PubMed
- NCBI
- Department of Health Care Service
- Trade Data Sources
- Trade Map
- UN Comtrade
- Trade Atlas
- Company Information
- OneSource Business Browser
- Hoover’s
- Factiva
- Bloomberg
- Mergers & Acquisitions
- Thomson Mergers & Acquisitions
- MergerStat
- Profound
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Infusion Therapy Market
- 4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Porter’s Five Force Analysis
- 5. Key Insights
- 5.1. Key Industry Developments
- 5.2. Disease Prevalence & Incidence Rate globally with key countries
- 5.3. Technological Advancements
- 5.4. Regulatory Scenario by Region/globally
- 5.5. Covid-19 Pandemic impact on the industry
- 6. Global Infusion Therapy Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017–2031
- 6.3.1. Infusion Pumps
- 6.3.1.1. Ambulatory Infusion Pumps
- 6.3.1.2. Stationary Infusion Pumps
- 6.3.1.3. Syringe Infusion Pumps
- 6.3.1.4. Disposable Pumps
- 6.3.1.5. Large Volume Pumps
- 6.3.1.6. Elastomeric Pumps
- 6.3.2. Infusion Set
- 6.3.3. Accessories
- 6.4. Market Attractiveness Analysis, by Product
- 7. Global Infusion Therapy Market Analysis and Forecast, by Indication
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Indication, 2017–2031
- 7.3.1. Cancer
- 7.3.2. Gastrointestinal Diseases / Disorders
- 7.3.3. Congestive Heart Failure
- 7.3.4. Rheumatoid Arthritis
- 7.3.5. Hemophilia
- 7.3.6. Immune Deficiencies
- 7.3.7. Others
- 7.4. Market Attractiveness Analysis, by Indication
- 8. Global Infusion Therapy Market Analysis and Forecast, by Therapy Type
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Therapy Type, 2017–2031
- 8.3.1. Antibiotic/Antiviral
- 8.3.2. Anti-coagulation
- 8.3.3. Anti-emetics
- 8.3.4. Blood Component Stimulating Factor
- 8.3.5. Chemotherapy
- 8.3.6. Nutrition
- 8.3.7. Hydration
- 8.3.8. Pain Management
- 8.4. Market Attractiveness Analysis, by Therapy Type
- 9. Global Infusion Therapy Market Analysis and Forecast, by End-user
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast, by End-user, 2017–2031
- 9.3.1. Hospitals
- 9.3.2. Ambulatory Surgical Centers
- 9.3.3. Clinics
- 9.3.4. Homecare Settings
- 9.4. Market Attractiveness Analysis, by End-user
- 10. Global Infusion Therapy Market Analysis and Forecast, by Region
- 10.1. Key Findings
- 10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness Analysis, by Region
- 11. North America Infusion Therapy Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Product, 2017–2031
- 11.2.1. Infusion Pumps
- 11.2.1.1. Ambulatory Infusion Pumps
- 11.2.1.2. Stationary Infusion Pumps
- 11.2.1.3. Syringe Infusion Pumps
- 11.2.1.4. Disposable Pumps
- 11.2.1.5. Large Volume Pumps
- 11.2.1.6. Elastomeric Pumps
- 11.2.2. Infusion Set
- 11.2.3. Accessories
- 11.3. Market Value Forecast, by Indication, 2017–2031
- 11.3.1. Cancer
- 11.3.2. Gastrointestinal Diseases / Disorders
- 11.3.3. Congestive Heart Failure
- 11.3.4. Rheumatoid Arthritis
- 11.3.5. Hemophilia
- 11.3.6. Immune Deficiencies
- 11.3.7. Others
- 11.4. Market Value Forecast, by Therapy Type, 2017–2031
- 11.4.1. Antibiotic/Antiviral
- 11.4.2. Anti-coagulation
- 11.4.3. Anti-emetics
- 11.4.4. Blood Component Stimulating Factor
- 11.4.5. Chemotherapy
- 11.4.6. Nutrition
- 11.4.7. Hydration
- 11.4.8. Pain Management
- 11.5. Market Value Forecast, by End-user, 2017–2031
- 11.5.1. Hospitals
- 11.5.2. Ambulatory Surgical Centers
- 11.5.3. Clinics
- 11.5.4. Homecare Settings
- 11.6. Market Value Forecast, by Country, 2017–2031
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Product
- 11.7.2. By Indication
- 11.7.3. By Therapy Type
- 11.7.4. By End-user
- 11.7.5. By Country
- 12. Europe Infusion Therapy Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Product, 2017–2031
- 12.2.1. Infusion Pumps
- 12.2.1.1. Ambulatory Infusion Pumps
- 12.2.1.2. Stationary Infusion Pumps
- 12.2.1.3. Syringe Infusion Pumps
- 12.2.1.4. Disposable Pumps
- 12.2.1.5. Large Volume Pumps
- 12.2.1.6. Elastomeric Pumps
- 12.2.2. Infusion Set
- 12.2.3. Accessories
- 12.3. Market Value Forecast, by Indication, 2017–2031
- 12.3.1. Cancer
- 12.3.2. Gastrointestinal Diseases / Disorders
- 12.3.3. Congestive Heart Failure
- 12.3.4. Rheumatoid Arthritis
- 12.3.5. Hemophilia
- 12.3.6. Immune Deficiencies
- 12.3.7. Others
- 12.4. Market Value Forecast, by Therapy Type, 2017–2031
- 12.4.1. Antibiotic/Antiviral
- 12.4.2. Anti-coagulation
- 12.4.3. Anti-emetics
- 12.4.4. Blood Component Stimulating Factor
- 12.4.5. Chemotherapy
- 12.4.6. Nutrition
- 12.4.7. Hydration
- 12.4.8. Pain Management
- 12.5. Market Value Forecast, by End-user, 2017–2031
- 12.5.1. Hospitals
- 12.5.2. Ambulatory Surgical Centers
- 12.5.3. Clinics
- 12.5.4. Homecare Settings
- 12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Italy
- 12.6.5. Spain
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Product
- 12.7.2. By Indication
- 12.7.3. By Therapy Type
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region
- 13. Asia Pacific Infusion Therapy Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Product, 2017–2031
- 13.2.1. Infusion Pumps
- 13.2.1.1. Ambulatory Infusion Pumps
- 13.2.1.2. Stationary Infusion Pumps
- 13.2.1.3. Syringe Infusion Pumps
- 13.2.1.4. Disposable Pumps
- 13.2.1.5. Large Volume Pumps
- 13.2.1.6. Elastomeric Pumps
- 13.2.2. Infusion Set
- 13.2.3. Accessories
- 13.3. Market Value Forecast, by Indication, 2017–2031
- 13.3.1. Cancer
- 13.3.2. Gastrointestinal Diseases / Disorders
- 13.3.3. Congestive Heart Failure
- 13.3.4. Rheumatoid Arthritis
- 13.3.5. Hemophilia
- 13.3.6. Immune Deficiencies
- 13.3.7. Others
- 13.4. Market Value Forecast, by Therapy Type, 2017–2031
- 13.4.1. Antibiotic/Antiviral
- 13.4.2. Anti-coagulation
- 13.4.3. Anti-emetics
- 13.4.4. Blood Component Stimulating Factor
- 13.4.5. Chemotherapy
- 13.4.6. Nutrition
- 13.4.7. Hydration
- 13.4.8. Pain Management
- 13.5. Market Value Forecast, by End-user, 2017–2031
- 13.5.1. Hospitals
- 13.5.2. Ambulatory Surgical Centers
- 13.5.3. Clinics
- 13.5.4. Homecare Settings
- 13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Product
- 13.7.2. By Indication
- 13.7.3. By Therapy Type
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region
- 14. Latin America Infusion Therapy Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Product, 2017–2031
- 14.2.1. Infusion Pumps
- 14.2.1.1. Ambulatory Infusion Pumps
- 14.2.1.2. Stationary Infusion Pumps
- 14.2.1.3. Syringe Infusion Pumps
- 14.2.1.4. Disposable Pumps
- 14.2.1.5. Large Volume Pumps
- 14.2.1.6. Elastomeric Pumps
- 14.2.2. Infusion Set
- 14.2.3. Accessories
- 14.3. Market Value Forecast, by Indication, 2017–2031
- 14.3.1. Cancer
- 14.3.2. Gastrointestinal Diseases / Disorders
- 14.3.3. Congestive Heart Failure
- 14.3.4. Rheumatoid Arthritis
- 14.3.5. Hemophilia
- 14.3.6. Immune Deficiencies
- 14.3.7. Others
- 14.4. Market Value Forecast, by Therapy Type, 2017–2031
- 14.4.1. Antibiotic/Antiviral
- 14.4.2. Anti-coagulation
- 14.4.3. Anti-emetics
- 14.4.4. Blood Component Stimulating Factor
- 14.4.5. Chemotherapy
- 14.4.6. Nutrition
- 14.4.7. Hydration
- 14.4.8. Pain Management
- 14.5. Market Value Forecast, by End-user, 2017–2031
- 14.5.1. Hospitals
- 14.5.2. Ambulatory Surgical Centers
- 14.5.3. Clinics
- 14.5.4. Homecare Settings
- 14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Product
- 14.7.2. By Indication
- 14.7.3. By Therapy Type
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region
- 15. Middle East & Africa Infusion Therapy Market Analysis and Forecast
- 15.1. Introduction
- 15.1.1. Key Findings
- 15.2. Market Value Forecast, by Product, 2017–2031
- 15.2.1. Infusion Pumps
- 15.2.1.1. Ambulatory Infusion Pumps
- 15.2.1.2. Stationary Infusion Pumps
- 15.2.1.3. Syringe Infusion Pumps
- 15.2.1.4. Disposable Pumps
- 15.2.1.5. Large Volume Pumps
- 15.2.1.6. Elastomeric Pumps
- 15.2.2. Infusion Set
- 15.2.3. Accessories
- 15.3. Market Value Forecast, by Indication, 2017–2031
- 15.3.1. Cancer
- 15.3.2. Gastrointestinal Diseases / Disorders
- 15.3.3. Congestive Heart Failure
- 15.3.4. Rheumatoid Arthritis
- 15.3.5. Hemophilia
- 15.3.6. Immune Deficiencies
- 15.3.7. Others
- 15.4. Market Value Forecast, by Therapy Type, 2017–2031
- 15.4.1. Antibiotic/Antiviral
- 15.4.2. Anti-coagulation
- 15.4.3. Anti-emetics
- 15.4.4. Blood Component Stimulating Factor
- 15.4.5. Chemotherapy
- 15.4.6. Nutrition
- 15.4.7. Hydration
- 15.4.8. Pain Management
- 15.5. Market Value Forecast, by End-user, 2017–2031
- 15.5.1. Hospitals
- 15.5.2. Ambulatory Surgical Centers
- 15.5.3. Clinics
- 15.5.4. Homecare Settings
- 15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
- 15.7. Market Attractiveness Analysis
- 15.7.1. By Product
- 15.7.2. By Indication
- 15.7.3. By Therapy Type
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region
- 16. Competition Landscape
- 16.1. Market Player - Competition Matrix (by tier and size of companies)
- 16.2. Market Share Analysis, by Company, 2021
- 16.3. Company Profiles
- 16.3.1. B. Braun Melsungen AG
- 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.1.2. Product Portfolio
- 16.3.1.3. Financial Overview
- 16.3.1.4. SWOT Analysis
- 16.3.1.5. Strategic Overview
- 16.3.2. Medtronic plc
- 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.2.2. Product Portfolio
- 16.3.2.3. Financial Overview
- 16.3.2.4. SWOT Analysis
- 16.3.2.5. Strategic Overview
- 16.3.3. Becton, Dickinson and Company
- 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.3.2. Product Portfolio
- 16.3.3.3. Financial Overview
- 16.3.3.4. SWOT Analysis
- 16.3.3.5. Strategic Overview
- 16.3.4. ICU medical (Smiths Medical)
- 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.4.2. Product Portfolio
- 16.3.4.3. Financial Overview
- 16.3.4.4. SWOT Analysis
- 16.3.4.5. Strategic Overview
- 16.3.5. Baxter International, Inc.
- 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.5.2. Product Portfolio
- 16.3.5.3. Financial Overview
- 16.3.5.4. SWOT Analysis
- 16.3.5.5. Strategic Overview
- 16.3.6. Polymedicure
- 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.6.2. Product Portfolio
- 16.3.6.3. Financial Overview
- 16.3.6.4. SWOT Analysis
- 16.3.6.5. Strategic Overview
- 16.3.7. BIO-MED
- 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.7.2. Product Portfolio
- 16.3.7.3. Financial Overview
- 16.3.7.4. SWOT Analysis
- 16.3.7.5. Strategic Overview
- 16.3.8. Terumo Medical Corporation
- 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.8.2. Product Portfolio
- 16.3.8.3. Financial Overview
- 16.3.8.4. SWOT Analysis
- 16.3.8.5. Strategic Overview
- 16.3.9. MEDIPRIM GmbH
- 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.9.2. Product Portfolio
- 16.3.9.3. Financial Overview
- 16.3.9.4. SWOT Analysis
- 16.3.9.5. Strategic Overview
- 16.3.10. Fresenius Kabi
- 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.10.2. Product Portfolio
- 16.3.10.3. Financial Overview
- 16.3.10.4. SWOT Analysis
- 16.3.10.5. Strategic Overview
- 16.3.11. Cardinal Health
- 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.11.2. Product Portfolio
- 16.3.11.3. Financial Overview
- 16.3.11.4. SWOT Analysis
- 16.3.11.5. Strategic Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook